How many RSU-related shares did Caris Life Sciences (CAI) withhold for John Russel Denton’s taxes?

Caris Life Sciences withheld 6,047 shares of common stock at $15.25 per share to cover Denton’s tax liability on vesting RSUs. This reduced the gross RSU shares he received but is treated as a routine, compensation-related disposition.

Caris Life Sciences (CAI) exec has 6,047 shares withheld for RSU taxes

Q: What are John Russel Denton’s Caris Life Sciences (CAI) share holdings after the transaction?

After the tax-withholding event, Denton directly held 181,515 shares of Caris Life Sciences common stock and indirectly held 9,184 shares through a trust. These figures reflect his reported ownership positions following the RSU vesting-related adjustment.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Caris Life Sciences executive John Russel Denton reported routine equity compensation activity. On May 15, 2026, 6,047 shares of common stock were withheld at $15.25 per share to cover taxes on the vesting and settlement of RSUs, a non‑market tax-withholding disposition coded "F".

Following this event, Denton directly held 181,515 shares of common stock and indirectly held 9,184 shares through a trust. The filing shows no open-market purchases or sales, indicating a compensation-related adjustment rather than a discretionary trade.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Denton John Russel

Role See Remarks

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	6,047	$15.25	$92K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 181,515 shares (Direct, null); Common Stock — 9,184 shares (Indirect, By Trust)

Footnotes (1)

[object Object]

Key Figures

Shares withheld for taxes: 6,047 shares Withholding price: $15.25 per share Direct holdings after transaction: 181,515 shares +1 more

4 metrics

Shares withheld for taxes 6,047 shares Tax-withholding disposition on May 15, 2026 for RSU vesting

Withholding price $15.25 per share Value used for 6,047 shares withheld for taxes

Direct holdings after transaction 181,515 shares Common stock directly owned following May 15, 2026 event

Indirect holdings by trust 9,184 shares Common stock held indirectly by trust as of May 15, 2026

Key Terms

RSUs, tax-withholding disposition, indirect ownership, Form 4

4 terms

RSUs financial

"taxes on the vesting and settlement of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

tax-withholding disposition financial

"transaction_action is described as a tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

indirect ownership financial

"9,184 shares reported as indirect ownership by trust"

Form 4 regulatory

"Caris Life Sciences reported this insider activity on Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/18/2026 - 04:23 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Denton John Russel

(Last)

(First)

(Middle)

C/O CARIS LIFE SCIENCES, INC.

750 W. JOHN CARPENTER FREEWAY, SUITE 800

(Street)

IRVING

TEXAS

75039

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Caris Life Sciences, Inc. [ CAI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/15/2026		F		6,047⁽¹⁾	D	$15.25	181,515	D
Common Stock								9,184	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares withheld for the payment of taxes on the vesting and settlement of RSUs.

Remarks:

Senior Vice President, General Counsel, and Secretary

	/s/ J. Russel Denton	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Caris Life Sciences (CAI) report for John Russel Denton?

Caris Life Sciences reported a Form 4 for executive John Russel Denton showing 6,047 shares withheld to cover taxes on vested RSUs. This was a compensation-related tax-withholding disposition, not an open-market stock sale or purchase.

How many Caris Life Sciences (CAI) shares were withheld for taxes in this Form 4?

The Form 4 shows 6,047 shares of Caris Life Sciences common stock withheld at $15.25 per share. These shares covered tax obligations arising from the vesting and settlement of restricted stock units (RSUs) granted as part of Denton’s compensation.

Did John Russel Denton sell Caris Life Sciences (CAI) shares on the market?

The filing does not show any open-market sales by Denton. Instead, 6,047 shares were withheld by the company to pay taxes on vested RSUs, a standard F-code tax-withholding disposition rather than a discretionary sale into the market.

What does transaction code F mean in the Caris Life Sciences (CAI) Form 4?

Transaction code F in this Form 4 indicates shares were used to pay an exercise price or tax liability. Here, 6,047 shares were withheld to satisfy taxes triggered when Denton’s RSUs vested and settled, rather than being sold on the open market.